Effect of pentoxifylline in vitro on neutrophil reactive oxygen production and phagocytic ability assessed by flow cytometry

Clinical Drug Investigation

Volumn 13, Issue 2, 1997, Pages 99-104

  Wenisch, Christoph ^a   Zedtwitz Liebenstein, Konstantin ^a   Parschalk, Bernhard ^a   Graninger, Wolfgang ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN RADICAL; PENTOXIFYLLINE; REACTIVE OXYGEN METABOLITE; RHODAMINE 123;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; GRANULOCYTE TRANSFUSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PLASMAPHERESIS; PRIORITY JOURNAL; SEPTICEMIA; TISSUE INJURY;

EID: 0031044530     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199713020-00006     Document Type: Article

References (16)

1. Bone RC. Inhibitors of complement and neutrophils: a critical evaluation of their role in the treatment of sepsis. Crit Care Med 1992; 20: 891-8
2. Buchanan MR, Vasquez MJ, Gimbrone AJ. Arachidonic acid metabolism and the adhesion of human polymorphonuclear leukocytes to cultured vascular endothelial cells. Blood 1983; 62: 889-95
3. Cronstein BN, Eberle MA, Gruber HE, et al. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991; 88: 2441-5
4. Cronstein BN, Kimmel SC, Levin RI, et al. A mechanism for the antiinflammatory effects of cortocosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of ELAM-1 and ICAM-1. Proc Natl Acad Sci USA 1992; 89: 9991-5
5. Issekutz AC,Chuluyan HE, Lopes N. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms. J Leukoc Biol 1995; 57: 553-61
6. Sullivan GW, Carper HT, Novick WJ, et al. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor alpha on neutrophil function by pentoxifylline. Infect Immun 1988; 56: 1722-9
7. Graninger W, Wenisch C. Pentoxifylline in severe inflammatory response syndrome. J Cardiovasc Pharmacol 1995; 25: 134-8
8. Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989; 320: 365-76
9. Baehner RL, Boxer LA, Allen JM, et al. Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood 1977; 50: 327-35
10. Sullivan GW, Carper HT, Novick WJ, et al. Pentoxifylline inhibits the inflammatory effects of endotoxin and endotoxin-induced cytokines on neutrophil function. In: Mandell GL, Novick WJ, editors. Pentoxifylline and leukocyte function. Somerville, NJ: Hoechst-Roussel Pharmaceuticals Inc.
11. Wenisch C, Parschalk B, Hasenhündl M, et al. Polymorphonuclear leukocyte dysregulation in patients with Gram-negative septicemia. Eur J Clin Invest 1995; 25: 418-24
12. Wenisch C, Graninger W. Are soluble factors relevant for PMN dysregulation in patients with Gram-negative septicemia? Clin Lab Diagnost Immunol 1995; 2: 241-5
13. Wenisch C, Parschalk B, Hasenhündl M, et al. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections. Antimicrob Agents Chemother 1995; 39: 672-6
14. Elbim C, Lefebvre M, Hakim J, et al. Effects of pentoxifylline on human polymorphonuclear neutrophil responses to TNF in whole blood. Eur Cytokine Netw 1995; 6: 113-20
15. Crouch SPM, Fletcher J. Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect Immun 1992; 60: 4504-9
16. Sullivan GW, Carper HT, Mandell GL. Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro. Antimicrob Agents Chemother 1992; 36: 408-16